Abstract 10867: CXCR3 Blockade Uncouples Immunotherapy-Induced Myocarditis from Anti-Tumor Immunity Through Oxygen-Dependent mTORC1/HIF1α Metabolic Adaptation
Background: Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy but can cause ICI myocarditis (ICIM), a potentially fatal complication driven by aberrant CD8 + T-cell responses. Current therapies reduce cardiac inflammation but may compromise anti-tumor immunity. We observed that CXCR3 inhibitio...